Thu, May 22 2014 - 6:30pm
David Ewing Duncan, Author, When I'm 164: The New Science of Radical Life Extension, and What Happens if It Succeeds and Experimental Man; Columnist, Newsweek; Chief Correspondent, NPR Talk’s Biotech Nation
In conversation with Becky Worley, Technology Contributor, ABC’s “Good Morning America”; Host, “Upgrade Your Life,” Yahoo! News
The average life expectancy of Americans is approximately 78 years, but how long do you really want to live? Today, scientists at universities and research institutions across the globe are discussing and working on anti-aging treatments that could possibly extend the average life span of humans by decades. In his book, When I’m 164, David Ewing Duncan explores the science of radical life extension and the new technologies that may alter the limits of human life. Join Duncan for a discussion on these advances in biotechnology and the impact and implications of being able to live to age 164 or beyond.